Eleonora Allocati
Impact in
-
- Antibiotic Use and Resistance
-
- Biosimilars and Bioanalytical Methods
Papers in
- Immunology 12
- Biosimilars and Bioanalytical Methods 12
-
- Pharmaceutical Economics and Policy 13
- Co-authors
- Brian Godman (5 shared papers)Chiara Gerardi (14 shared papers)Rita Banzi (5 shared papers)Silvio K. Garattini (3 shared papers)Attilio Guarini (9 shared papers)Marco Gobbi (3 shared papers)Carla Minoia (9 shared papers)Evelien Moorkens (2 shared papers)
- Journals
- Cancers (8 papers)Generics and Biosimilars Initiative Journal (3 papers)Frontiers in Pharmacology (2 papers)Surgical Endoscopy (2 papers)Hematological Oncology (1 paper)
- Partner nations
- ItalyUnited KingdomSouth Africa
In The Last Decade
Eleonora Allocati
31 papers receiving 430 citations
Peers
Comparison fields: 5 of 57
- Applied Microbiology and Biotechnology 19
- Immunology 147
- General Dentistry 3
- Economics and Econometrics 149
- Endocrinology, Diabetes and Metabolism 46
Countries citing papers authored by Eleonora Allocati
This map shows the geographic impact of Eleonora Allocati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Allocati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Allocati more than expected).
Fields of papers citing papers by Eleonora Allocati
This network shows the impact of papers produced by Eleonora Allocati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Allocati. The network helps show where Eleonora Allocati may publish in the future.
Co-authors
The 25 scholars most cited alongside Eleonora Allocati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 57 | |
| 2 | 2021 | 56 | |
| 3 | 2021 | 44 | |
| 4 | 2021 | 32 | |
| 5 | 2022 | 30 | |
| 6 | 2021 | 24 | |
| 7 | 2021 | 21 | |
| 8 | 2021 | 17 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 12 | |
| 13 | 2019 | 10 | |
| 14 | 2021 | 10 | |
| 15 | 2020 | 9 | |
| 16 | Availability and use of long-acting insulin analogues including their biosimilars across Africa; findings and implications | 2021 | 9 |
| 17 | 2020 | 8 | |
| 18 | 2021 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2022 | 7 |
About Eleonora Allocati
Eleonora Allocati is a scholar working on Immunology, Economics and Econometrics, Oncology, Pathology and Forensic Medicine and Emergency Medicine, having authored 33 papers that have together received 438 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (13 papers), Biosimilars and Bioanalytical Methods (12 papers), Cancer survivorship and care (5 papers), Multiple and Secondary Primary Cancers (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Appendicitis Diagnosis and Management (2 papers), Bariatric Surgery and Outcomes (1 paper) and Cancer-related cognitive impairment studies (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (19 citations), Immunology (147 citations), General Dentistry (3 citations), Economics and Econometrics (149 citations) and Endocrinology, Diabetes and Metabolism (46 citations). Eleonora Allocati has collaborated with scholars based in Italy, United Kingdom and South Africa. Frequent co-authors include Brian Godman, Chiara Gerardi, Rita Banzi, Silvio K. Garattini, Attilio Guarini, Marco Gobbi, Carla Minoia, Evelien Moorkens, Hye-Young Kwon and Vitaliana De Sanctis. Their work appears in journals such as Cancers, Generics and Biosimilars Initiative Journal, Frontiers in Pharmacology, Surgical Endoscopy and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.